| 11.01 -0.09 (-0.81%) | 03-12 13:48 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 12.98 | 1-year : | 15.17 |
| Resists | First : | 11.11 | Second : | 12.98 |
| Pivot price | 11.04 |
|||
| Supports | First : | 10.92 | Second : | 10.81 |
| MAs | MA(5) : | 11.05 |
MA(20) : | 11 |
| MA(100) : | 10.82 |
MA(250) : | 10.55 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 72.1 |
D(3) : | 82.6 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 12.89 | Low : | 10.19 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ DTSQ ] has closed above bottom band by 35.4%. Bollinger Bands are 29% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.11 - 11.18 | 11.18 - 11.23 |
| Low: | 10.77 - 10.86 | 10.86 - 10.92 |
| Close: | 10.9 - 11.03 | 11.03 - 11.12 |
DT Cloud Star Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2022 and is based in Brooklyn, New York.
Mon, 09 Mar 2026
Crossingbridge Advisors Reduces Stake in DT Cloud Star Acquisition - National Today
Mon, 09 Mar 2026
Crossingbridge Advisors LLC Sells 125,000 Shares of DT Cloud Star Acquisition Corporation $DTSQ - MarketBeat
Fri, 06 Feb 2026
Blank check company led by an executive from CITIC Securities (pending: PrimeGen US). - renaissancecapital.com
Wed, 04 Feb 2026
Biotech Firm PrimeGen To Go Public In SPAC Deal - Nasdaq
Wed, 04 Feb 2026
DT Cloud Star to Merge with PrimeGen US - TipRanks
Wed, 04 Feb 2026
Stem cell biotech PrimeGen lines up $1.5B deal for liver treatment push - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Financial - Conglomerates
|
|
| Shares Out | 4 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 87.2 (%) |
| Held by Institutions | 34.7 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 2 (K) |
| EPS | 0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.08 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -0.5 % |
| Return on Equity (ttm) | 7.4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -15.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 34.4 |
| PEG Ratio | 0 |
| Price to Book value | -137.63 |
| Price to Sales | 0 |
| Price to Cash Flow | -94.62 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |